Neuberger Berman Group LLC Acquires 248 Shares of Atrion Co. (NASDAQ:ATRI)

Neuberger Berman Group LLC raised its holdings in shares of Atrion Co. (NASDAQ:ATRI) by 0.1% during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 184,767 shares of the medical instruments supplier’s stock after acquiring an additional 248 shares during the quarter. Neuberger Berman Group LLC owned approximately 0.10% of Atrion worth $114,727,000 as of its most recent SEC filing.

A number of other large investors have also bought and sold shares of the business. Franklin Resources Inc. raised its holdings in Atrion by 0.8% during the second quarter. Franklin Resources Inc. now owns 10,673 shares of the medical instruments supplier’s stock valued at $6,627,000 after acquiring an additional 82 shares during the period. Stifel Financial Corp increased its holdings in shares of Atrion by 7.7% in the second quarter. Stifel Financial Corp now owns 2,235 shares of the medical instruments supplier’s stock worth $1,388,000 after purchasing an additional 160 shares during the last quarter. Bridgewater Associates LP bought a new stake in shares of Atrion in the second quarter worth about $1,180,000. Geode Capital Management LLC increased its holdings in shares of Atrion by 0.4% in the second quarter. Geode Capital Management LLC now owns 24,270 shares of the medical instruments supplier’s stock worth $15,069,000 after purchasing an additional 94 shares during the last quarter. Finally, Dimensional Fund Advisors LP increased its holdings in shares of Atrion by 3.0% in the second quarter. Dimensional Fund Advisors LP now owns 53,380 shares of the medical instruments supplier’s stock worth $33,144,000 after purchasing an additional 1,576 shares during the last quarter. 64.29% of the stock is currently owned by institutional investors and hedge funds.

Separately, TheStreet raised Atrion from a “c+” rating to a “b-” rating in a report on Wednesday, August 25th.

Shares of ATRI stock opened at $703.77 on Thursday. Atrion Co. has a 12-month low of $567.00 and a 12-month high of $783.84. The stock’s 50-day moving average price is $693.79 and its 200-day moving average price is $647.31. The stock has a market capitalization of $1.29 billion, a price-to-earnings ratio of 41.23 and a beta of 0.08.

Atrion (NASDAQ:ATRI) last released its quarterly earnings results on Monday, August 9th. The medical instruments supplier reported $4.88 EPS for the quarter. The company had revenue of $42.69 million during the quarter. Atrion had a return on equity of 12.97% and a net margin of 21.14%.

The business also recently declared a quarterly dividend, which was paid on Thursday, September 30th. Investors of record on Wednesday, September 15th were given a $1.95 dividend. The ex-dividend date was Tuesday, September 14th. This represents a $7.80 annualized dividend and a yield of 1.11%. This is a positive change from Atrion’s previous quarterly dividend of $1.75.

Atrion Profile

Atrion Corp. engages in the manufacture and development of products for medical applications. It offers products fro cardiovascular, fluid delivery, and ophthalmic. It also offers contract manufacturing & kitting services; and marine & aviation inflation components. The company was founded in 1944 and is headquartered in Allen, TX.

See Also: How to Invest in an Index Fund

Want to see what other hedge funds are holding ATRI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Atrion Co. (NASDAQ:ATRI).

Institutional Ownership by Quarter for Atrion (NASDAQ:ATRI)

Receive News & Ratings for Atrion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Atrion and related companies with MarketBeat.com's FREE daily email newsletter.